Investing

Summit Therapeutics : SMMT

SMMT

Stock Data

$14.47

$0.60 (3.97%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Summit Therapeutics Inc is a biopharmaceutical firm based in Miami, Florida, dedicated to advancing healthcare with innovative medicinal therapies. It specializes in developing treatments for challenging diseases, with a focus on immunotherapy and anti-infectives. Its leading project, Ivonescimab, is a pioneering bispecific antibody aimed at enhancing immunotherapy by targeting PD-1 and blocking angiogenesis. Additionally, Summit is working on SMT-738, a new class of precision antibiotics designed to combat multidrug-resistant infections. The company collaborates with Akeso, Inc. to bring ivonescimab to market, showcasing its commitment to addressing unmet medical needs.

All Summit Therapeutics Articles

5 Articles

Alex Sirois | May 4, 2026 at 11:07 AM EDT

Buy These 3 Clinical-Stage Biotechs Under $30 With Solid Cash Runways

Clinical-stage biotech is one of the few corners of the market where a sub-$30 share price genuinely matters: small-cap oncology…

Omor Ibne Ehsan | Oct 28, 2025 at 2:21 PM EDT

Insiders Are Buying These 3 Stocks Hand Over Fist

Insider buys can be a telltale sign of a turnaround, as these investments give you a window into where management…

Trey Thoelcke | Oct 25, 2025 at 8:45 AM EDT

Insiders Are Scooping Up Shares of a Miner, a Driller, and a Biotech

In the past week or so, a gold and silver miner, an offshore driller, and a biotech saw some huge…

Trey Thoelcke | Sep 17, 2025 at 8:45 AM EDT

Elon Musk Leads Insider Buying Wave

The highlight of recent insider buying is an enormous purchase of Tesla shares by CEO Elon Musk. But it wasn't…

Ian Cooper | Sep 16, 2025 at 10:04 AM EDT

Insiders Are Aggressively Buying These 5 Stocks

Insiders know their company the best. So, if they’re buying a good deal of shares, there’s often a reason for…